Regulation of pharmaceutical innovation : The 1962 amendments

The production of these effects would not necessarily tell us anything about the costs and benefits of the 1962 amendments. The costs and benefits would depend on the value of the particular drugs kept off the market by the amendments and the value of the information on new drugs generated by more e...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Peltzman, Sam
Format: Llibre
Idioma:Undetermined
Publicat: Washington American Enterprise Institute for Public Policy Research 1974
Matèries:
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
Thư viện lưu trữ: Trung tâm Học liệu Trường Đại học Cần Thơ